register

News & Trends - Pharmaceuticals

AMA, RACGP and Medicines Australia mourn the sad loss of Dr Harry Nespolon

Health Industry Hub | July 28, 2020 |

Pharma News: The AMA joins with the Royal Australian College of General Practice (RACGP), Medicines Australia and the wider medical community in mourning the sad loss of RACGP President, Dr Harry Nespolon following a battle with pancreatic cancer.

AMA President Dr Tony Bartone, who is also a member of the RACGP, said that Dr Nespolon would be sorely missed across General Practice.

“I’ve worked alongside Harry in advocacy for General Practice, for the medical profession, and our patients for years,” Dr Bartone said.

“Harry was a great defender of General Practice. He stood up for doctors. He and I spent many hours working with government officials to improve our health care system for the better. He simply was passionate about his patients and their care.

“Even during the final stages of his illness, Harry kept working full pace on behalf of General Practitioners.

“Indeed; in the last few months, my interactions with Harry augmented significantly in proportion to the enormous policy settings in discussion around General Practice. He always was present.

“Harry will be sorely missed, and I offer the condolences of all at the AMA to the Nespolon family and our RACGP colleagues,” Dr Bartone said.

Dr Nespolon has made an immense contribution to Medicines Australia and to the industry. He has been a valuable member of the Medicines Australia Code of Conduct Committee for over 15 years. Dr Nespolon’s unfailing determination to uphold ethical behaviour, along with his ability to make rational decisions, quickly made him an integral part of the Committee. Never afraid to make a statement, or ask a challenging question, Dr Nespolon’s contribution to this committee will be sorely missed.

According to Medicines Australia, Dr Nespolon showed great leadership of the RACGP during the COVID-19 Crisis. His tireless work advocating for continuity of care, and strong criticism of misinformation being spread demonstrated his passion for his profession.

In addition to his role as RACGP President, Dr Nespolon made a significant contribution to the wider health system through his participation in a number of organisations that covered General Practice training, primary care and the hospital sector.

Dr Nespolon also worked for a period at the AMA Federal Secretariat in the 1990s.


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech join Research Australia and DHCRC in welcoming funding for medical research and One Stop Shop

Medicines Australia and AusBiotech join Research Australia and Digital Health CRC in welcoming funding of national strategy for medical research and National One Stop Shop

Health Industry Hub | May 2, 2024 |

Pharma News: Medicines Australia, AusBiotech, Research Australia and the Digital Health Cooperative Research Centre (DHCRC) applaud the funding announcement of […]

More


News & Trends - MedTech & Diagnostics

Health insurers clash with government decision on GUIs, prompting threat of premium hikes

Health insurers clash with government on GUIs decision, prompting threat of premium hikes

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]

More


News & Trends - MedTech & Diagnostics

Catheter ablation underused in atrial fibrillation despite proven efficacy

Catheter ablation underused in atrial fibrillation despite proven efficacy

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]

More


News & Trends - Biotechnology

How prepared are we for the next pandemic?

How prepared are we for the next pandemic?

Health Industry Hub | May 2, 2024 |

Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]

More


This content is copyright protected. Please subscribe to gain access.